Taysha Gene Therapies Inc... (TSHA)

AI Score

Unlock

1.24

0.06 (5.08%)

At close: Apr 17, 2025, 3:59 PM

1.21

-2.42%

After-hours: Apr 17, 2025, 07:01 PM EDT

Taysha Gene Therapies Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019
Net Income	-89.3M	-22.77M	-114.33M	-118M	-111.57M	-215.03M	-124.25M	-133.53M	-166.01M	-160.68M	-185.56M	-192.61M	-174.52M	-142.46M	-106.31M	-86.6M	-60.01M	-42.81M	-27.77M	-6.55M	-1.11M
Depreciation & Amortization	1.25M	1.31M	1.34M	1.36M	1.37M	1.37M	1.31M	1.25M	1.17M	1.02M	906K	717K	492K	289K	126K	41K	9K	3K	n/a	n/a	n/a
Stock-Based Compensation	13.1M	11.86M	10.54M	9.43M	7.91M	10.04M	12.47M	14.39M	18.04M	18.89M	19.51M	19.92M	18.18M	15.24M	11.5M	6.95M	3.35M	1.34M	n/a	n/a	n/a
Other Working Capital	-3.98M	-6.5M	-14.15M	-14.04M	-15.72M	20M	26.28M	21.23M	26.32M	-2.24M	-5.47M	14.91M	14.17M	7.53M	8.47M	-3.99M	-2.07M	1.03M	1.22M	912K	n/a
Other Non-Cash Items	473K	-56.5M	-54M	-49.99M	-49.86M	45.58M	42.74M	38.88M	39.89M	4.8M	6.08M	6.08M	10.14M	10.2M	13.04M	30.05M	27.37M	25.35M	21.01M	3.8M	980K
Deferred Income Tax	n/a	-3.93M	97.14M	97.14M	97.14M	101.07M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-6.9M	-9.14M	-16.2M	-12.72M	-18.01M	14.34M	14.39M	11.24M	18.52M	-6.96M	12.86M	30.08M	28.67M	20.09M	11.58M	-160K	-111K	6.57M	2.59M	1.05M	135K
Operating Cash Flow	-81.24M	-79.05M	-75.39M	-72.65M	-73.02M	-42.62M	-53.33M	-67.77M	-88.39M	-142.93M	-146.2M	-135.81M	-117.04M	-96.63M	-71.42M	-51.06M	-30.73M	-10.88M	-4.17M	-1.7M	n/a
Capital Expenditures	-374K	-393K	-3.86M	-3.61M	-7.37M	-9.66M	-9.18M	-17.34M	-24.87M	-31.08M	-32.06M	-32.45M	-21.55M	-19.09M	-15.11M	-6.62M	-6.08M	-31K	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	11K	7K	17K	17K	17K	-51K	-1.06M	-1.31M	-4.31M	-4.5M	-4M	-9.25M	-6.25M	-12M	-11.5M	-9M	-9M	-3M	-3M	n/a	n/a
Investing Cash Flow	-363K	-386K	-3.84M	-3.59M	-7.35M	-9.71M	-9.24M	-17.4M	-24.93M	-31.08M	-32.06M	-32.45M	-21.55M	-19.09M	-15.11M	-9.62M	-9.08M	-3.03M	-3M	n/a	n/a
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	9.98M	39.96M	39.96M	39.96M	29.98M	n/a	1K	28K	28K	28K	27K	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	-68K	-68K	-68K	-68K	n/a	n/a	n/a	-1.31M	-1.31M	-1.31M	-1.31M	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	70.36M	66.53M	66.52M	-3.58M	-3.9M	-9K	-188K	-1.05M	-775K	-1.71M	-1.45M	-965K	-874K	-95.81M	71.58M	71.32M	89.32M	185.13M	17.74M	18M	n/a
Financial Cash Flow	76.7M	72.81M	206.85M	136.76M	136.39M	182.31M	41.42M	51.97M	52.1M	19.54M	49.77M	38.84M	39.08M	28.5M	272.7M	273.04M	291.06M	292.55M	18.36M	18.03M	n/a
Net Cash Flow	-2.75M	-3.99M	128.11M	61M	56.51M	129.97M	-21.16M	-33.2M	-61.22M	-154.47M	-128.49M	-129.42M	-99.51M	-87.22M	186.17M	212.36M	251.25M	278.63M	11.2M	16.33M	n/a
Free Cash Flow	-81.62M	-79.44M	-79.24M	-76.26M	-80.39M	-52.28M	-62.51M	-85.11M	-113.26M	-174M	-178.26M	-168.26M	-138.6M	-115.72M	-86.53M	-57.68M	-36.81M	-10.91M	-4.17M	-1.7M	n/a